[1]
“THE IMPACT OF IMMUNOHISTOCHEMICAL MARKER INDICATORS ON TREATMENT OUTCOMES IN ENDOMETRIAL ATYPICAL HYPERPLASIA”, Wor.Bul.Pub.Helt., vol. 52, pp. 46–50, Dec. 2025, Accessed: Apr. 02, 2026. [Online]. Available: https://scholarexpress.net/index.php/wbph/article/view/5680